Local and global firms lead $3.2b India pharma deal

April 11, 2014 Shearman & Sterling, Crawford Bayley & Co and S. H. Bathiya & Associates have taken leading roles on Sun Pharmaceutical’s takeover of Diiachi Sankyo-owned Ranbaxy Laboratories. The $3.2 billion all-stock deal is the biggest ever transaction in the Indian pharmaceutical industry and creates the world’s fifth-largest generic drug manufacturer,

Luthra & Luthra Law Offices and Amarchand & Mangaldas & Suresh A. Shroff & Co advised Ranbaxy, while Daiichi Sankyo was guided by Davis Polk & Wardwell and Amarchand.

comments powered by Disqus